Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
356,030
-
Share change
-
+7,562
-
Total reported value
-
$22,850,385
-
Price per share
-
$64.18
-
Number of holders
-
13
-
Value change
-
+$692,908
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q1 2021
As of 31 Mar 2021,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
356,030 shares.
The largest 10 holders included
Parametric Portfolio Associates LLC, ZEVIN ASSET MANAGEMENT LLC, Hemenway Trust Co LLC, Boston Common Asset Management, LLC, ST GERMAIN D J CO INC, HIGH POINTE CAPITAL MANAGEMENT LLC, Moloney Securities Asset Management, LLC, The PNC Financial Services Group, Inc., CAPTRUST FINANCIAL ADVISORS, and MAR VISTA INVESTMENT PARTNERS LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.